Epidemiology of antifungal resistance in human pathogenic yeasts: current viewpoint and practical recommendations for management.

In this review, we describe the epidemiology and clinical significance of resistance in Candida spp. and other non-Cryptococcus yeasts.

The rise in echinocandin resistance, azole resistance and cross-resistance to two or more antifungal classes [multidrug resistance (MDR)] has been a worrisome trend, mainly in US large tertiary and oncology centres, particularly as it relates to Candida glabrata. Candida kefyr is also a concern as it can be resistant to echinocandins and polyenes, especially in patients with haematological malignancies.

Lately, Candida auris has drawn a lot of attention: this uncommon Candida spp. is the first globally emerging fungal pathogen that exhibits MDR and strong potential for nosocomial transmission. Its almost simultaneous spread in four continents could be indicative of increasing selection pressures from the use of antifungal agents. Echinocandin non-susceptibility is also common among non-Candida, non-Cryptococcus yeasts.

EpiQuik Nuclear Extraction Kit II (Nucleic Acid-Free)

OP-0022 100 Extractions
EUR 292.15
Description: kits suitable for this type of research

Native Bacteria Achromopeptidase

NATE-0022 1g
EUR 475

Donkey Anti-Goat IgG (H+L) Affinipure

FNSA-0022 500 uL
EUR 341.4
Description: Donkey Anti-Goat IgG (H+L) Affinipure secondary antibody

Human complement factor D,CFD ELISA Kit

201-12-0320 96 tests
EUR 440
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

ELISA kit for PGI2 (Prostacyclin)

E-EL-0022 1 plate of 96 wells
EUR 377
Description: A competitive ELISA kit for quantitative measurement of PGI2 (Prostacyclin) in samples from Serum, Plasma, Cell supernatant

Fast-Pfu with 10mM dNTP Mix (250U)

9K-001-0022 250U
EUR 402.35

2X Pfu PCR Premix (5 x 1mL)

9K-002-0022 5X1mL, 5ml
EUR 581.14

Human thyroxine,T4 ELISA Kit

201-12-0022 96 tests
EUR 440
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

As Candida resistance patterns reflect, in part, institutional practices of antifungal administration, the benefits of antifungal stewardship protocols are increasingly recognised and endorsed in recent guidelines. Development of rapid diagnostic methods for detecting or ruling out the presence of candidaemia and antifungal resistance, as well as discovery of novel antifungals, are key priorities in medical mycologyresearch.